NCT03612726 The Overall Survival of Patients With Unresectable HCC in Real-life Status RECRUITING Phase N/A
NCT03609151 Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT03608878 Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in HCC Patients With GALNT14-rs9679162-non-TT Genotype Status TERMINATED Phase PHASE2
NCT03606590 Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA) Status COMPLETED Phase PHASE2
NCT03594188 Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy Status COMPLETED Phase NA
NCT03592706 Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy Status UNKNOWN Phase PHASE2/PHASE3
NCT03591965 Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects Status TERMINATED Phase PHASE2
NCT03586050 Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea Status COMPLETED Phase NA
NCT03582618 CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma Status TERMINATED Phase PHASE2
NCT03578874 SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC Status COMPLETED Phase PHASE2
NCT03575806 Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection Status COMPLETED Phase PHASE2
NCT03551444 Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial Status UNKNOWN Phase PHASE3
NCT03539822 Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT03538028 A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03534141 Mild Hypothermia and Acute Kidney Injury in Liver Transplantation Status TERMINATED Phase NA
NCT03520257 The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus Status UNKNOWN Phase PHASE2
NCT03519997 A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT03518502 Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis Status UNKNOWN Phase PHASE4